Health Care & Life Sciences » Biotechnology | LegoChem Biosciences Inc.

LegoChem Biosciences Inc.

LegoChem Biosciences Inc.
Stock Exchange Korea Exchange
EPS
KRW1049
Market Cap
KRW450.6 B
Shares Outstanding
10.59 M
Public Float
7.8 M

Profile

Address
8-26 Munpyeongseo-ro
Daejeon DE 34302
Korea, Republic Of
Employees -
Website http://www.legochembio.com
Updated 09/14/2018
LegoChem Biosciences, Inc. engages in the development and manufacturing of pharmaceuticals. Its main therapeutic areas include antibiotics, anti-coagulants, oncology, antibody-drug conjugate and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.

Financials

View All

Yong-Zu Kim
Chief Executive Officer & Director
Beop-Pyo Lee
Director, Vice President, Head-Medicine